Annual CFF
$5000.00
-$33.29 M-99.98%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual cash flow from financing activities is $5000.00, with the most recent change of -$33.29 million (-99.98%) on December 31, 2022.
- During the last 3 years, DFFN annual CFF has fallen by -$16.04 million (-99.97%).
Performance
DFFN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly cash flow from financing activities is $0.00, unchanged on June 30, 2023.
- Over the past year, DFFN quarterly CFF has stayed the same.
Performance
DFFN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$0.00
$0.000.00%
June 30, 2023
Summary
- As of February 10, 2025, DFFN TTM cash flow from financing activities is $0.00, unchanged on June 30, 2023.
- Over the past year, DFFN TTM CFF has dropped by -$5000.00 (-100.00%).
Performance
DFFN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DFFN Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -100.0% | 0.0% | -100.0% |
3 y3 years | -100.0% | -100.0% | -100.0% |
5 y5 years | -100.0% | +100.0% | -100.0% |
DFFN Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -100.0% | at low | -100.0% | at low | -100.0% | at low |
5 y | 5-year | -100.0% | at low | -100.0% | <-9999.0% | -100.0% | at low |
alltime | all time | -100.0% | -100.0% | -100.0% | <-9999.0% | -100.0% | <-9999.0% |
Diffusion Pharmaceuticals Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2022 | $5000.00(-100.0%) | $0.00(0.0%) | $5000.00(0.0%) |
Sep 2022 | - | $0.00(0.0%) | $5000.00(0.0%) |
Jun 2022 | - | $0.00(-100.0%) | $5000.00(0.0%) |
Mar 2022 | - | $5000.00(>+9900.0%) | $5000.00(-100.0%) |
Dec 2021 | $33.30 M(+86.1%) | $0.00(0.0%) | $33.30 M(0.0%) |
Sep 2021 | - | $0.00(0.0%) | $33.30 M(+0.4%) |
Jun 2021 | - | $0.00(-100.0%) | $33.15 M(-35.0%) |
Mar 2021 | - | $33.30 M(>+9900.0%) | $51.03 M(+185.2%) |
Dec 2020 | $17.89 M(+11.5%) | $0.00(-100.0%) | $17.89 M(-36.9%) |
Sep 2020 | - | -$141.40 K(-100.8%) | $28.37 M(-0.2%) |
Jun 2020 | - | $17.88 M(>+9900.0%) | $28.43 M(+75.5%) |
Mar 2020 | - | $155.20 K(-98.5%) | $16.20 M(+1.0%) |
Dec 2019 | $16.04 M(+62.6%) | $10.48 M(<-9900.0%) | $16.04 M(+188.1%) |
Sep 2019 | - | -$80.20 K(-101.4%) | $5.57 M(-1.4%) |
Jun 2019 | - | $5.65 M(>+9900.0%) | $5.65 M(-879.4%) |
Mar 2019 | - | $0.00(0.0%) | -$724.80 K(-107.3%) |
Dec 2018 | $9.87 M(-51.0%) | $0.00(0.0%) | $9.87 M(+0.3%) |
Sep 2018 | - | $0.00(-100.0%) | $9.84 M(+24.5%) |
Jun 2018 | - | -$724.80 K(-106.8%) | $7.90 M(-52.5%) |
Mar 2018 | - | $10.59 M(<-9900.0%) | $16.63 M(-17.3%) |
Dec 2017 | $20.12 M(+1002.3%) | -$28.00 K(-98.6%) | $20.12 M(+0.1%) |
Sep 2017 | - | -$1.93 M(-124.2%) | $20.10 M(-16.0%) |
Jun 2017 | - | $8.01 M(-43.2%) | $23.91 M(+50.3%) |
Mar 2017 | - | $14.08 M(<-9900.0%) | $15.91 M(+771.3%) |
Dec 2016 | $1.83 M(-23.5%) | -$54.30 K(-102.9%) | $1.83 M(-2.9%) |
Sep 2016 | - | $1.88 M(>+9900.0%) | $1.88 M(>+9900.0%) |
Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2016 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2015 | $2.39 M(-92.2%) | - | - |
Dec 2014 | $30.71 M(+2623.7%) | $76.70 K(-105.6%) | $30.71 M(+0.3%) |
Sep 2014 | - | -$1.37 M(-104.3%) | $30.63 M(-5.8%) |
Jun 2014 | - | $31.61 M(+7801.4%) | $32.52 M(+2349.4%) |
Mar 2014 | - | $400.00 K(>+9900.0%) | $1.33 M(+17.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2013 | $1.13 M(-75.1%) | $0.00(-100.0%) | $1.13 M(-59.4%) |
Sep 2013 | - | $510.00 K(+22.2%) | $2.78 M(-5.5%) |
Jun 2013 | - | $417.50 K(+108.7%) | $2.94 M(-0.7%) |
Mar 2013 | - | $200.00 K(-87.9%) | $2.96 M(-34.5%) |
Dec 2012 | $4.52 M(-65.5%) | $1.65 M(+145.5%) | $4.52 M(+11.5%) |
Sep 2012 | - | $673.30 K(+54.1%) | $4.06 M(-2.7%) |
Jun 2012 | - | $437.00 K(-75.2%) | $4.17 M(-70.8%) |
Mar 2012 | - | $1.76 M(+48.4%) | $14.30 M(+9.1%) |
Dec 2011 | $13.11 M(+289.5%) | $1.19 M(+51.3%) | $13.11 M(+1.1%) |
Sep 2011 | - | $784.00 K(-92.6%) | $12.97 M(-0.4%) |
Jun 2011 | - | $10.57 M(+1746.6%) | $13.02 M(+380.6%) |
Mar 2011 | - | $572.20 K(-45.3%) | $2.71 M(-19.5%) |
Dec 2010 | $3.37 M(+165.1%) | $1.05 M(+25.1%) | $3.37 M(+21.0%) |
Sep 2010 | - | $836.60 K(+229.8%) | $2.78 M(+36.5%) |
Jun 2010 | - | $253.70 K(-79.3%) | $2.04 M(-15.0%) |
Mar 2010 | - | $1.23 M(+165.4%) | $2.40 M(+88.9%) |
Dec 2009 | $1.27 M(+150.6%) | $462.90 K(+397.7%) | $1.27 M(+32.1%) |
Sep 2009 | - | $93.00 K(-84.9%) | $960.90 K(+7.0%) |
Jun 2009 | - | $613.90 K(+516.4%) | $898.20 K(+76.4%) |
Mar 2009 | - | $99.60 K(-35.5%) | $509.30 K(+0.5%) |
Dec 2008 | $506.60 K(>+9900.0%) | $154.40 K(+409.6%) | $506.60 K(-426.0%) |
Sep 2008 | - | $30.30 K(-86.5%) | -$155.40 K(-309.4%) |
Jun 2008 | - | $225.00 K(+132.2%) | $74.20 K(-321.5%) |
Mar 2008 | - | $96.90 K(-119.1%) | -$33.50 K(<-9900.0%) |
Dec 2007 | $0.00(0.0%) | -$507.60 K(-295.3%) | $0.00(-100.0%) |
Sep 2007 | - | $259.90 K(+121.6%) | $507.60 K(+104.9%) |
Jun 2007 | - | $117.30 K(-10.0%) | $247.70 K(+90.0%) |
Mar 2007 | - | $130.40 K(>+9900.0%) | $130.40 K(>+9900.0%) |
Dec 2006 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2006 | - | $0.00 | $0.00 |
Dec 2005 | $75.00 K(-99.2%) | - | - |
Dec 1999 | $9.32 M(+22.6%) | - | - |
Dec 1998 | $7.60 M | - | - |
FAQ
- What is Diffusion Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual CFF year-on-year change?
- What is Diffusion Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly CFF year-on-year change?
- What is Diffusion Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals TTM CFF year-on-year change?
What is Diffusion Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of DFFN is $5000.00
What is the all time high annual CFF for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual cash flow from financing activities is $33.30 M
What is Diffusion Pharmaceuticals annual CFF year-on-year change?
Over the past year, DFFN annual cash flow from financing activities has changed by -$33.29 M (-99.98%)
What is Diffusion Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of DFFN is $0.00
What is the all time high quarterly CFF for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly cash flow from financing activities is $33.30 M
What is Diffusion Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, DFFN quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Diffusion Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of DFFN is $0.00
What is the all time high TTM CFF for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high TTM cash flow from financing activities is $51.03 M
What is Diffusion Pharmaceuticals TTM CFF year-on-year change?
Over the past year, DFFN TTM cash flow from financing activities has changed by -$5000.00 (-100.00%)